Dexcom's total assets for Q2 2025 were $7.33B, an increase of 8.52% from the previous quarter. DXCM total liabilities were $4.75B for the fiscal quarter, a 5.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.